Signals from intestinal microbiota mediate the crosstalk between the lung-gut axis in an influenza infection mouse

Yijia Zhang1, Youdi Wan1, Xin Xin1

  • 1Laboratory of Animal Neurobiology, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.

PubMed
Abstract

Insights

Influenza infection damages lungs and intestines, altering gut bacteria and metabolites. Supplementing with tryptophan and Lactobacillus alleviates this damage, revealing a crucial lung-intestine connection in disease.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Influenza virus primarily affects the respiratory system, but causes damage to both respiratory and intestinal tracts.
  • The precise link between lung and intestinal damage during influenza infection is not well understood.

Purpose of the Study:

  • To investigate the impact of influenza virus infection on intestinal microbiota and metabolites.
  • To elucidate the mechanisms underlying influenza-induced intestinal damage and the lung-intestine axis.

Main Methods:

  • 16S rRNA sequencing and Liquid Chromatography-Mass Spectrometry (LC-MS) for microbial and metabolic profiling.
  • Histopathology (HE staining), Western blot, Q-PCR, and flow cytometry to assess intestinal damage and immune responses.
  • In vivo mouse model of influenza infection with and without antibiotic treatment or supplementation.

Main Results:

  • Influenza infection caused significant lung and intestinal damage, with the virus localized to the lungs.
  • Antibiotic treatment exacerbated both lung and intestinal damage, reduced microbial diversity, and altered metabolite profiles.
  • Influenza infection disrupted intestinal microbiota (increased Enterobacteriaceae, decreased Lactobacillaceae) and amino acid metabolism, leading to an imbalance in T helper 17 (Th17) and regulatory T cells (Treg cells) via indoleamine 2,3-dioxygenase 1 (IDO1) pathway.
  • Supplementation with tryptophan and Lactobacillus ameliorated lung and intestinal damage, reduced Enterobacteriaceae, and restored Th17/Treg balance.

Conclusions:

  • Influenza infection induces significant lung and intestinal pathology, mediated by gut dysbiosis and metabolic alterations.
  • Antibiotics worsen influenza-induced damage, underscoring the importance of a balanced gut microbiota.
  • Tryptophan and Lactobacillus supplementation represent a potential therapeutic strategy for mitigating influenza-induced intestinal disease by restoring gut homeostasis and immune balance.